Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA fills new position with APhA exec

Executive Summary

FDA appoints American Pharmacists Association VP-Policy & Communications Susan Winckler to the new position of director for policy communications. Winckler will have primary responsibility for developing and implementing advisory committee policy and will help coordinate public participation in FDA policymaking. Winckler represented APhA in Prescription Drug User Fee Act reauthorization discussions (1"The Pink Sheet" Nov. 28, 2005, p. 11)...

You may also be interested in...



FDA chief of staff

FDA appoints Susan Winckler as acting chief of staff. Winckler replaces Patrick Ronan who was chief of staff since August 2005. Before joining FDA as director for policy communications, Winckler served as VP of policy and communications for the American Pharmacists Association (1"The Pink Sheet" Sept. 18, 2006, In Brief). Winckler will begin her new role in early January...

PDUFA Provides Opportunity For Conditional Approvals, Consumer Groups Say

Consumer groups are advocating the creation of a "conditional" approval authority for FDA through the reauthorization of the Prescription Drug User Fee Act

Inovio Confirms Frontrunner Status In COVID-19 Vaccine Race, But Can It Prove Skeptics Wrong?

Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.

UsernamePublicRestriction

Register

PS047572

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel